The prevention of cancer and development of more effective strategies to detect precursors and early-stage cancers, when treatment may be most effective, remain critical societal goals.
The 2020 Bionow Oncology Conference will present the problems that we face with prevention and early diagnosis and discuss the latest advances to address these challenges and translate the science into better care for the cancer patient. In addition to leading experts we will also hear about this challenge from the patient’s perspective.
Cancer is always a complex question and there are no simple answers which is why it’s important to hear from those at the cutting edge of developments.
Geoff Davison, CEO, Bionow
Allan Jordan, Director - Oncology Drug Discovery, Sygnature Discovery
Chair: Jonathan Perkins, Associate Director - Personalised Healthcare, QIAGEN
Will Dracup, CEO, Early Diagnostics Institute
Alexis Webb, Senior Research Funding Manager, Cancer Reserch UK
Andy Chaloner, CEO, Stream Bio
Sameer Kothari, Chief Executive Director, Zilico
To be Confirmed
Chair: Peter Simpson, Chief Scientific Officer, Medicines Discovery Catapult
Mark Wigglesworth, Director - High Throughput Screening, AstraZeneca
Robert Falconer, Professor Medicinal Chemistry, Bradford University
Richard Weaver, CEO, Xenogesis
Sally Peyman, University Academic Fellow, University of Leeds
Alastair Richards, CEO, NW Cancer Research
To be Confirmed
Chair: Jane Kendrew, Head of Science Services, Alderley Park
Kim Rockley, ApconiX
Juliana Maynard, Lead Scientist, Medicines Discovery Catapult
Chair: Paul Stott, CEO, Seda Pharmaceutical Development Services
Mike Frodsham, Chief Technical Officer, Quay Pharma
Peter York, Chairman, Crystec Pharma
Claire Patterson, Senior Principal Scientist, Seda Pharmaceutical Development Services
Alyn McNaughton, Technical Director, Lonza
Chair: AZO Network
David Howat, Director of Therapeutics, Stream Bio
Claire Thompson, CEO, Agility Health Tech
Steve McConchie, CEO, Aptus Clinical
Representative from National Physical Laboratory
The Bionow Oncology Conference offers a number exciting of sponsorship opportunities. All sponsorship packages can be tailored to meet the needs of your business and maximise your marketing potential and brand awareness.
Further details can be found HERE
|Gold Exhibitor Package||Silver Exhibitor Package|
|Exhibition Space with table and two chairs||Exhibition space with table and two chairs|
|Two delegate passes||One delegate pass|
|Company logo on delegate list||Company logo on delegate list|
|Recognition as gold exhibitor via Twitter / Linked-in||-|
|Company marketing materials in delegate bag||-|
There is no better way to showcase new developments, ongoing research projects and speculative or innovative work in progress relating to the study of cancer.
Authors are invited to submit an abstract which is related to the area cancer research. The posters are intended to provide authors and participants with a greater understanding of the subject matter and to engage in discussions about the work.
Further details are available below:
2020 Oncology Conference Call for Posters